Sponsors (34)
The bill provides a targeted, additional federal investment to expand gun‑violence research and signal congressional support for prevention, at the cost of roughly $300 million in spending and potential political controversy without guaranteeing broader programmatic actions.
Researchers, public-health agencies, hospitals, and patients gain dedicated funding: $50 million per year (FY2026–2031) for firearm safety and gun-violence prevention research, expanding capacity for evidence-based interventions.
Researchers and scientific institutions receive funds that are explicitly additional to existing authorizations, increasing total federal research funding rather than replacing prior amounts.
Taxpayers, hospitals, and communities could benefit over time from improved evidence that informs policies to reduce firearm injuries and deaths, potentially lowering long-term health care and societal costs.
Taxpayers bear increased federal spending: the authorization totals about $300 million over six years, which could raise outlays or necessitate budget offsets.
Some members of the public and stakeholders may view targeted federal funding for gun-violence research as politically controversial, which could reduce trust in findings or hinder uptake of research-driven policies.
Naming the law without additional programmatic guarantees could create public expectations of broader action on gun-violence prevention that are not assured by this legislation alone.
Based on analysis of 2 sections of legislative text.
Authorizes $50 million per year (FY2026–2031) for the CDC to conduct or support firearms safety and gun violence prevention research, in addition to other authorized amounts.
Introduced July 29, 2025 by Marilyn Strickland · Last progress July 29, 2025
Authorizes $50 million per year for the Centers for Disease Control and Prevention from fiscal year 2026 through 2031 to conduct or support research on firearms safety and gun violence prevention under the Public Health Service Act. The funding is specified as additional to any other amounts authorized for that purpose. The measure sets a six-year authorization of funding for CDC research activities but does not itself appropriate the money; actual spending would require future appropriations consistent with this authorization.